vs
Funko, Inc.（FNKO）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Funko, Inc.的季度营收约是Orthofix Medical Inc.的1.2倍（$273.1M vs $219.9M），Funko, Inc.净利率更高（-0.1% vs -1.0%，领先0.9%），Orthofix Medical Inc.同比增速更快（2.0% vs -7.0%），Funko, Inc.自由现金流更多（$19.2M vs $16.8M），过去两年Funko, Inc.的营收复合增速更高（12.5% vs 8.0%）
Funko是一家美国知名流行文化周边收藏品牌，主打获得IP授权的限量收藏商品，以 vinyl 搪胶收藏人偶和摇头公仔闻名，同时也生产授权毛绒玩具、可动玩偶、服饰、配件及周边桌游。该品牌由迈克·贝克尔与克劳迪娅·贝克尔于1998年创立，最初只是主打复古怀旧风的小型手工玩具项目。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FNKO vs OFIX — 直观对比
营收规模更大
FNKO
是对方的1.2倍
$219.9M
营收增速更快
OFIX
高出9.0%
-7.0%
净利率更高
FNKO
高出0.9%
-1.0%
自由现金流更多
FNKO
多$2.4M
$16.8M
两年增速更快
FNKO
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.1M | $219.9M |
| 净利润 | $-183.0K | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 2.2% | 0.2% |
| 净利率 | -0.1% | -1.0% |
| 营收同比 | -7.0% | 2.0% |
| 净利润同比 | 87.8% | 92.4% |
| 每股收益（稀释后） | $0.00 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNKOOFIX
| Q4 25 | $273.1M | $219.9M | ||
| Q3 25 | $250.9M | $205.6M | ||
| Q2 25 | $193.5M | $203.1M | ||
| Q1 25 | $190.7M | $193.6M | ||
| Q4 24 | $293.7M | $215.7M | ||
| Q3 24 | $292.8M | $196.6M | ||
| Q2 24 | $247.7M | $198.6M | ||
| Q1 24 | $215.7M | $188.6M |
净利润FNKOOFIX
| Q4 25 | $-183.0K | $-2.2M | ||
| Q3 25 | $901.0K | $-22.8M | ||
| Q2 25 | $-40.5M | $-14.1M | ||
| Q1 25 | $-27.6M | $-53.1M | ||
| Q4 24 | $-1.5M | $-29.1M | ||
| Q3 24 | $4.3M | $-27.4M | ||
| Q2 24 | $5.1M | $-33.4M | ||
| Q1 24 | $-22.7M | $-36.0M |
毛利率FNKOOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | 40.9% | 68.7% | ||
| Q2 24 | 42.0% | 67.8% | ||
| Q1 24 | 40.0% | 67.5% |
营业利润率FNKOOFIX
| Q4 25 | 2.2% | 0.2% | ||
| Q3 25 | 2.6% | -8.3% | ||
| Q2 25 | -18.0% | -7.9% | ||
| Q1 25 | -12.2% | -25.2% | ||
| Q4 24 | 1.8% | -5.3% | ||
| Q3 24 | 4.0% | -9.6% | ||
| Q2 24 | 4.3% | -12.5% | ||
| Q1 24 | -6.9% | -15.6% |
净利率FNKOOFIX
| Q4 25 | -0.1% | -1.0% | ||
| Q3 25 | 0.4% | -11.1% | ||
| Q2 25 | -20.9% | -6.9% | ||
| Q1 25 | -14.5% | -27.4% | ||
| Q4 24 | -0.5% | -13.5% | ||
| Q3 24 | 1.5% | -13.9% | ||
| Q2 24 | 2.1% | -16.8% | ||
| Q1 24 | -10.5% | -19.1% |
每股收益（稀释后）FNKOOFIX
| Q4 25 | $0.00 | $-0.05 | ||
| Q3 25 | $0.02 | $-0.57 | ||
| Q2 25 | $-0.74 | $-0.36 | ||
| Q1 25 | $-0.52 | $-1.35 | ||
| Q4 24 | $-0.01 | $-0.76 | ||
| Q3 24 | $0.08 | $-0.71 | ||
| Q2 24 | $0.10 | $-0.88 | ||
| Q1 24 | $-0.45 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.1M | $82.0M |
| 总债务越低越好 | $100.3M | — |
| 股东权益账面价值 | $185.8M | $450.0M |
| 总资产 | $685.2M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.54× | — |
8季度趋势，按日历期对齐
现金及短期投资FNKOOFIX
| Q4 25 | $42.1M | $82.0M | ||
| Q3 25 | $39.2M | $62.9M | ||
| Q2 25 | $49.2M | $65.6M | ||
| Q1 25 | $25.9M | $58.0M | ||
| Q4 24 | $34.7M | $83.2M | ||
| Q3 24 | $28.5M | $30.1M | ||
| Q2 24 | $41.6M | $26.4M | ||
| Q1 24 | $26.1M | $27.0M |
总债务FNKOOFIX
| Q4 25 | $100.3M | — | ||
| Q3 25 | $106.0M | $157.2M | ||
| Q2 25 | $111.6M | $157.0M | ||
| Q1 25 | $117.2M | $156.9M | ||
| Q4 24 | $122.8M | $157.0M | ||
| Q3 24 | $128.4M | $118.5M | ||
| Q2 24 | $133.9M | $118.0M | ||
| Q1 24 | $139.4M | $118.2M |
股东权益FNKOOFIX
| Q4 25 | $185.8M | $450.0M | ||
| Q3 25 | $182.7M | $442.5M | ||
| Q2 25 | $181.2M | $458.3M | ||
| Q1 25 | $212.8M | $458.3M | ||
| Q4 24 | $233.0M | $503.1M | ||
| Q3 24 | $236.5M | $525.9M | ||
| Q2 24 | $223.5M | $546.0M | ||
| Q1 24 | $212.5M | $570.3M |
总资产FNKOOFIX
| Q4 25 | $685.2M | $850.6M | ||
| Q3 25 | $699.3M | $832.6M | ||
| Q2 25 | $694.9M | $837.2M | ||
| Q1 25 | $648.4M | $823.1M | ||
| Q4 24 | $707.3M | $893.3M | ||
| Q3 24 | $783.6M | $867.9M | ||
| Q2 24 | $737.8M | $882.0M | ||
| Q1 24 | $725.5M | $906.0M |
负债/权益比FNKOOFIX
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.58× | 0.36× | ||
| Q2 25 | 0.62× | 0.34× | ||
| Q1 25 | 0.55× | 0.34× | ||
| Q4 24 | 0.53× | 0.31× | ||
| Q3 24 | 0.54× | 0.23× | ||
| Q2 24 | 0.60× | 0.22× | ||
| Q1 24 | 0.66× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $19.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 7.0% | 7.6% |
| 资本支出强度资本支出/营收 | 3.3% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-38.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FNKOOFIX
| Q4 25 | $28.1M | $27.7M | ||
| Q3 25 | $11.2M | $12.4M | ||
| Q2 25 | $-22.2M | $11.6M | ||
| Q1 25 | $-22.3M | $-18.4M | ||
| Q4 24 | $59.8M | $23.7M | ||
| Q3 24 | $3.3M | $11.7M | ||
| Q2 24 | $45.9M | $9.0M | ||
| Q1 24 | $14.5M | $-18.6M |
自由现金流FNKOOFIX
| Q4 25 | $19.2M | $16.8M | ||
| Q3 25 | $3.4M | $2.5M | ||
| Q2 25 | $-31.8M | $4.5M | ||
| Q1 25 | $-28.8M | $-25.1M | ||
| Q4 24 | $47.8M | $15.2M | ||
| Q3 24 | $-4.2M | $6.3M | ||
| Q2 24 | $36.8M | $-360.0K | ||
| Q1 24 | $10.3M | $-29.1M |
自由现金流率FNKOOFIX
| Q4 25 | 7.0% | 7.6% | ||
| Q3 25 | 1.3% | 1.2% | ||
| Q2 25 | -16.5% | 2.2% | ||
| Q1 25 | -15.1% | -13.0% | ||
| Q4 24 | 16.3% | 7.0% | ||
| Q3 24 | -1.4% | 3.2% | ||
| Q2 24 | 14.9% | -0.2% | ||
| Q1 24 | 4.8% | -15.4% |
资本支出强度FNKOOFIX
| Q4 25 | 3.3% | 4.9% | ||
| Q3 25 | 3.1% | 4.8% | ||
| Q2 25 | 5.0% | 3.5% | ||
| Q1 25 | 3.4% | 3.5% | ||
| Q4 24 | 4.1% | 4.0% | ||
| Q3 24 | 2.6% | 2.7% | ||
| Q2 24 | 3.7% | 4.7% | ||
| Q1 24 | 1.9% | 5.6% |
现金转化率FNKOOFIX
| Q4 25 | — | — | ||
| Q3 25 | 12.47× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.77× | — | ||
| Q2 24 | 8.97× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FNKO
| Core Collectibles | $221.0M | 81% |
| Loungefly LLC | $43.1M | 16% |
| Other Products Excluding Core Collectibles And Loungefly Brands | $9.0M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
